Genetics News and Research

Latest Genetics News and Research

Wireless technology and data systems transforming health care

News outlets report on the way that health information technology is changing the practice of medicine.

12 Apr 2010

U-M Medical School researchers earn $366M in NIH research funding in fiscal year 2009

University of Michigan Medical School physicians and scientists earned more than $366 million in National Institutes of Health research funding in federal fiscal year 2009, according to NIH data. In all, the School's faculty brought in more than $435 million in research funding from all sources in U-M fiscal year 2009.

12 Apr 2010

Ku protein employs unique mechanism for DNA repair: Researchers

Scientists have shown in multiple contexts that DNA damage over our lifetimes is a key mechanism behind the development of cancer and other age-related diseases. Not everyone gets these diseases, because the body has multiple mechanisms for repairing the damage caused to DNA by aging, the environment and other human behaviors - but the mechanisms behind certain kinds of DNA repair have not been well-understood.

12 Apr 2010

Latest advancement in the development of lab tests for bipolar disorder

Genetic testing may rise to a new level with the findings of Indiana University School of Medicine researchers whose "prototype" for laboratory testing for bipolar disorder appears today in the online edition of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

9 Apr 2010

Recql5 identified as a tumor suppressor in GI tract

Recql5 is a member of the mammalian RecQ helicase family. Genetic mutations that result in loss of RecQ helicase activity give rise to disorders that are associated with cancer predisposition and premature aging, such as Bloom, Werner, and Rothmund-Thomson syndromes. This class of enzymes is best known for their role in maintaining the integrity of the genome to prevent oncogenic mutations.

9 Apr 2010

World's largest autism science and advocacy organization awards 16 new research grants

Autism Speaks, the world's largest autism science and advocacy organization, today announced the awarding of 16 new research grants totaling $5,223,743 over the next three years.

9 Apr 2010

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

A five-year, $3.7 million clinical trial will investigate how to balance the benefits and risks of warfarin, a drug that helps prevent potentially deadly blood clots.

9 Apr 2010

Fate Therapeutics to acquire Ottawa biotechnology company Verio Therapeutics

Fate Therapeutics, Inc. announced today a definitive agreement to acquire Verio Therapeutics Inc., a privately held biotechnology company based in Ottawa, Ontario, which is developing drug candidates targeting the activation of endogenous stem cells. Verio Therapeutics is advancing the work of several of Canada's leading stem cell scientists, including Michael Rudnicki, Ph.D., FRSC, and Lynn Arthur Megeney, Ph.D., who have made breakthrough discoveries relating to muscle and pancreatic regeneration.

9 Apr 2010

UBC doctoral candidate discovers a mechanism for silencing retroviruses

A University of British Columbia doctoral candidate has discovered a previously unknown mechanism for silencing retroviruses, segments of genetic material that can lead to fatal mutations in a cell's DNA.

8 Apr 2010

Scientific evidence links high levels of copper and iron to age-related disorders

With scientific evidence linking high levels of copper and iron to Alzheimer's disease, heart disease, and other age-related disorders, a new report in ACS' Chemical Research in Toxicology suggests specific steps that older consumers can take to avoid build up of unhealthy amounts of these metals in their bodies.

8 Apr 2010

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.

8 Apr 2010

Unique collaboration in fetal medicine among Columbus' healthcare professionals

The Columbus Fetal Medicine Collaborative has been formed by Mount Carmel Health System, OhioHealth, The Ohio State University Medical Center and Nationwide Children's Hospital joining together to provide optimal outcomes for high-risk expectant mothers and their babies with suspected fetal abnormalities.

8 Apr 2010

Prague hosts 12th European Congress of Endocrinology

The 12th European Congress of Endocrinology is taking place in Prague from 24-28 April 2010.

8 Apr 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Teva Pharmaceutical Industries Ltd. today announced that several new studies supporting the company's innovative central nervous system portfolio will be presented at the 62nd American Academy of Neurology Annual Meeting in Toronto, April 10-17, 2010.

8 Apr 2010

Researchers discover two genetic regions that influence birth weight

New research uncovers two genetic regions that influence birth weight. One of the regions is also associated with type 2 diabetes, which helps to explain why small babies have higher rates of diabetes in later life.

8 Apr 2010

Is grandmother’s age significant to autism?

A report just published in the online journal, PLoS ONE, indicates that the mothers of children with an autistic spectrum disorder were themselves more likely to have been born to older mothers. These findings could open up new avenues in autism research.

8 Apr 2010

Implementation of electronic health record systems may not be enough to improve health quality

The implementation of electronic health record systems may not be enough to significantly improve health quality and reduce costs. In the April 2010 issue of Health Affairs, researchers from the Mongan Institute for Health Policy at Massachusetts General Hospital report finding that currently implemented systems have little effect on measures such as patient mortality, surgical complications, length of stay and costs.

7 Apr 2010

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

The Muscular Dystrophy Association (MDA), headquartered in Tucson, Ariz., and Friends of FSH Research (FFSHR), based in Kirkland, Wash., has jointly awarded a two-year, $200,000 grant to Dr. Joel Chamberlain, a research assistant professor of medical genetics at the University of Washington. The grant, equally funded by the two organizations, will enable the laboratory led by Dr. Chamberlain to study RNA interference as an investigative and therapeutic tool for facioscapulohumeral muscular dystrophy.

7 Apr 2010

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

The Semel Institute for Neuroscience and Human Behavior at UCLA has been awarded $14.9 million in American Recovery and Reinvestment Act funds to establish a center dedicated to interdisciplinary research on the role of genetic and environmental factors in neuropsychiatric and behavioral disorders.

7 Apr 2010

IAN survey gives grandparents a voice in autism research community

Today, the Interactive Autism Network, www.ianproject.org, the nation's largest online autism research project, announces results of the Grandparents of Children with Autism Spectrum Disorders Survey, finding that nearly one-third of grandparents who participated were the first to raise concerns about their grandchild's development.

7 Apr 2010

Genetics News and Research

Latest Genetics News and Research

Wireless technology and data systems transforming health care

U-M Medical School researchers earn $366M in NIH research funding in fiscal year 2009

Ku protein employs unique mechanism for DNA repair: Researchers

Latest advancement in the development of lab tests for bipolar disorder

Recql5 identified as a tumor suppressor in GI tract

World's largest autism science and advocacy organization awards 16 new research grants

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

Fate Therapeutics to acquire Ottawa biotechnology company Verio Therapeutics

UBC doctoral candidate discovers a mechanism for silencing retroviruses

Scientific evidence links high levels of copper and iron to age-related disorders

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Unique collaboration in fetal medicine among Columbus' healthcare professionals

Prague hosts 12th European Congress of Endocrinology

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Researchers discover two genetic regions that influence birth weight

Is grandmother’s age significant to autism?

Implementation of electronic health record systems may not be enough to improve health quality

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

IAN survey gives grandparents a voice in autism research community

Sequencing & Genomics: Elevating Science and Healthcare eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging